Circulating Tumor DNA as a Potential Prognostic Marker in Patients with Borderline-Resectable Pancreatic Cancer Undergoing Neoadjuvant Chemotherapy Followed by Pancreatectomy
Yuji Kitahata, Manabu Kawai, Seiko Hirono, Ken‐ichi Okada, Motoki Miyazawa, Hideki Motobayashi, Masaki Ueno, Shinya Hayami, Atsushi Miyamoto, Hiroki Yamaue
Topics & Concepts
MedicineSurgical oncologyHazard ratioInternal medicinePancreatectomyLiquid biopsyPancreatic cancerGastroenterologyChemotherapyOncologyKRASBiopsyCancerBiomarkerPancreasConfidence intervalColorectal cancerChemistryBiochemistryCancer Genomics and DiagnosticsPancreatic and Hepatic Oncology ResearchCancer Cells and Metastasis